Certolizumab pegol, a monthly subcutaneously administered Fc-free anti-TNFalpha, improves health-related quality of life in patients with moderate to severe Crohn's disease
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Paul Rutgeerts Brian G. Feagan Richard N. Fedorak Stefan Schreiber Dorothy L Keininger |
| Publication date | December 11, 2007 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |